Bonhomme Fanny, Boehlen Françoise, Clergue François, de Moerloose Philippe
Department of Anesthesiology, Pharmacology and Intensive Care, Geneva University Hospitals, 4 rue Gabrielle Perret-Gentil, 1211, Geneva 14, Switzerland.
Division of Angiology and Hemostasis, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
Can J Anaesth. 2016 Sep;63(9):1007-15. doi: 10.1007/s12630-016-0688-9. Epub 2016 Jul 1.
Current recommendations for the assessment of the risk of perioperative bleeding limit coagulation testing to patients with a personal and/or family history of bleeding. As no simple preoperative screening questionnaire is currently available, we assessed the performance of a novel screening questionnaire for its ability to detect bleeding disorders.
A dichotomized, seven-point questionnaire named HEMSTOP (Hematoma, hEmorrhage, Menorrhagia, Surgery, Tooth extraction, Obstetrics, Parents) was applied to three groups of subjects: patients referred to hemostasis specialists for bleeding symptoms for whom any kind of perioperative hemostatic precautions were subsequently recommended (n = 38); patients referred to hemostasis specialists for whom precautions were not required (n = 75); healthy volunteers (n = 70). We calculated the sensitivity and specificity of HEMSTOP scores and compared them with the discriminative performances of standard blood coagulation assays (prothrombin time, activated partial thromboplastin time).
Patients requiring perioperative hemostatic precautions had greater median [interquartile range] HEMSTOP scores (2 [2-3]) than patients not requiring precautions (1 [1-2]) and healthy controls (0 [0-0]); P < 0.001. A HEMSTOP score ≥ 2 had a specificity of 98.6% [95% confidence interval (CI), 92.3 to 100] and a sensitivity of 89.5% (95% CI, 75.2 to 97.1). The 26.3% (95% CI, 13.4 to 43.1) sensitivity of the standard coagulation times was much lower.
The HEMSTOP score discriminates patients at an elevated risk for bleeding with recommended perioperative precautions from those without such recommendations as well as from healthy participants. Further evaluation of the HEMSTOP score is required for a better evaluation of its definitive usefulness to predict the risk of perioperative bleeding.
目前关于围手术期出血风险评估的建议将凝血功能检测限制在有个人和/或家族出血史的患者中。由于目前尚无简单的术前筛查问卷,我们评估了一种新型筛查问卷检测出血性疾病的能力。
一种名为HEMSTOP(血肿、出血、月经过多、手术、拔牙、产科、父母)的二分制七点问卷应用于三组受试者:因出血症状转诊至止血专家处且随后被建议采取任何围手术期止血预防措施的患者(n = 38);转诊至止血专家处但无需采取预防措施的患者(n = 75);健康志愿者(n = 70)。我们计算了HEMSTOP评分的敏感性和特异性,并将其与标准凝血试验(凝血酶原时间、活化部分凝血活酶时间)的鉴别性能进行比较。
需要围手术期止血预防措施的患者的HEMSTOP评分中位数[四分位间距](2[2 - 3])高于无需预防措施的患者(1[1 - 2])和健康对照者(0[0 - 0]);P < 0.001。HEMSTOP评分≥2时,特异性为98.6%[95%置信区间(CI),92.3至100],敏感性为89.5%(95%CI,75.2至97.1)。标准凝血时间的敏感性为26.3%(95%CI,13.4至43.1),要低得多。
HEMSTOP评分能够区分有围手术期出血风险且被建议采取预防措施的患者与未被建议采取此类措施的患者以及健康参与者。需要对HEMSTOP评分进行进一步评估,以更好地评估其预测围手术期出血风险的最终实用性。